Skip to main content
Fig. 4 | BMC Microbiology

Fig. 4

From: Antimicrobial potential of myricetin-coated zinc oxide nanocomposite against drug-resistant Clostridium perfringens

Fig. 4

Relative expression of C. perfringens alpha-hemolysin (plc) upon treatment with sub-MIC (MIC/2) of MYR or ZnO, ZnO/PVA, and ZnO/PVA/MYR. The fold change was determined by qRT-PCR, calculated using the ΔΔCT method, and normalized comparatively to 16S rDNA expression. The experiments were done in triplicate and each column represented the mean ± SEM

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us